Table 3 Summary statistics of secondary continuous outcome analyses in the ITT population
Descriptive statistics | Mixed model analysis | |||||||
|---|---|---|---|---|---|---|---|---|
THP-TAP | WHO-THP | Crude analysis | Adjusted analysisa | |||||
n | Mean (s.d.) | n | Mean (s.d.) | Difference (95% CI) | P value | Difference (95% CI) | P value | |
PHQ-9 (9-item Patient Health Questionnaire) | ||||||||
3 months | 428 | 3.25 (4.24) | 418 | 4.33 (5.78) | −1.13 (−1.96, −0.31) | 0.0071 | −1.09 (−1.90, −0.28) | 0.0082 |
6 months | 421 | 3.18 (4.37) | 410 | 3.41 (4.76) | −0.31 (−1.14, 0.52) | 0.4632 | −0.27 (−1.08, 0.54) | 0.5181 |
GAD-7 (Generalized Anxiety Disorder 7-Items) | ||||||||
3 months | 428 | 2.93 (3.89) | 418 | 3.00 (3.91) | −0.06 (−0.68, 0.57) | 0.8617 | −0.09 (−0.71, 0.53) | 0.7812 |
6 months | 421 | 2.83 (3.85) | 410 | 2.76 (3.66) | 0.08 (−0.55, 0.71) | 0.8007 | 0.05 (−0.57, 0.67) | 0.8720 |
WHO-DAS (WHO Disability Assessment Schedule) | ||||||||
3 months | 428 | 3.37 (5.29) | 418 | 4.09 (6.35) | −0.74 (−1.60, 0.13) | 0.0943 | −0.76 (−1.62, 0.09) | 0.0809 |
6 months | 421 | 2.78 (5.35) | 410 | 2.69 (5.12) | 0.07 (−0.80, 0.94) | 0.8671 | 0.05 (−0.81, 0.92) | 0.9025 |
